Trial Profile
Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Busulfan (Primary) ; Fludarabine (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- Acronyms RICE-NK
- 18 Jan 2011 Planned initiation date changed from 1 Sep 2010 to 1 Sep 2011 according to ClinicalTrials.gov.
- 14 Jul 2010 New trial record